DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+13.3%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$118M
AUM Growth
+$118M
Cap. Flow
-$8.57M
Cap. Flow %
-7.25%
Top 10 Hldgs %
44.84%
Holding
84
New
17
Increased
12
Reduced
22
Closed
11

Top Buys

1
LOXO
Loxo Oncology, Inc
LOXO
$6.77M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$3.99M
3
CLLS
Cellectis
CLLS
$1.83M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
$1.57M
5
BLRX
BioLineRX
BLRX
$961K

Top Sells

1
GLPG icon
Galapagos
GLPG
$2.65M
2
CYTK icon
Cytokinetics
CYTK
$2.56M
3
DERM
Dermira, Inc.
DERM
$2.41M
4
AERI
Aerie Pharmaceuticals, Inc.
AERI
$2.34M
5
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
$2.1M

Sector Composition

1 Healthcare 85.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASND icon
51
Ascendis Pharma
ASND
$12.1B
$510K 0.43%
18,214
-34,786
-66% -$974K
RCKT icon
52
Rocket Pharmaceuticals
RCKT
$358M
$474K 0.4%
59,284
– –
EIGR
53
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$412K 0.35%
1,199
-141
-11% -$48.5K
SRRA
54
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$405K 0.34%
+6,625
New +$405K
CBAY
55
DELISTED
Cymabay Therapeutics
CBAY
$379K 0.32%
+88,067
New +$379K
ABEO icon
56
Abeona Therapeutics
ABEO
$356M
$338K 0.29%
2,701
-371
-12% -$46.4K
CYAD
57
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$328K 0.28%
12,528
– –
MASI icon
58
Masimo
MASI
$7.43B
$326K 0.28%
3,500
-6,500
-65% -$605K
OBSV
59
DELISTED
ObsEva SA Ordinary Shares
OBSV
$260K 0.22%
+25,000
New +$260K
BLCM
60
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$247K 0.21%
+2,000
New +$247K
AXSM icon
61
Axsome Therapeutics
AXSM
$6.09B
$217K 0.18%
+55,700
New +$217K
AFMD
62
DELISTED
Affimed
AFMD
$213K 0.18%
+9,250
New +$213K
PVLA
63
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$139K 0.12%
669
-2,123
-76% -$441K
DMK
64
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$128K 0.11%
+429
New +$128K
ANAB icon
65
AnaptysBio
ANAB
$630M
$125K 0.11%
+4,500
New +$125K
TNXP icon
66
Tonix Pharmaceuticals
TNXP
$243M
– –
0
– –
TMBR
67
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$58K 0.05%
8
+3
+60% +$21.8K
SLS icon
68
SELLAS Life Sciences
SLS
$187M
$28K 0.02%
+31
New +$28K
ABUS icon
69
Arbutus Biopharma
ABUS
$753M
– –
-234,000
Closed -$573K
CYTK icon
70
Cytokinetics
CYTK
$5.98B
– –
-210,306
Closed -$2.56M
EPIX icon
71
ESSA Pharma
EPIX
$11.2M
– –
-4,902
Closed -$289K
PTGX icon
72
Protagonist Therapeutics
PTGX
$3.62B
– –
-45,586
Closed -$1M
AVGR
73
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$93K
FSTX
74
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-6,853
Closed -$219K
CNCE
75
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-66,968
Closed -$689K
1 2
3
4